Frontlight ResearchEarly access
Trial site
Center for Cognitive Health
- 2running trials
- 4closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Lewy body dementia1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Alzheon Inc.2 trials
- EIP Pharma Inc1 trial
Running trials
Closed trials
Terminated
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
Completed
RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
Completed
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Completed
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects
Site data: ClinicalTrials.govUpdated 12 Nov 2026